To: Stock
Exchange
|
For
immediate release:
|
|
16 April
2024
|
CT Private Equity Trust
PLC
Annual Financial Report for the
Year to 31 December 2023
Following the release on 3 April
2024 of the Company's preliminary results announcement for the year
ended 31 December 2023 (the "Preliminary Announcement"), the
Company announces that its annual report and financial statements
for the year ended 31 December 2023 (the "Annual Report and
Financial Statements") will be published today.
The information below, which is
extracted in unedited full text from the Annual Report and
Financial Statements, is included in this announcement solely for
the purposes of compliance with Disclosure and Transparency Rule
6.3.5 and the requirements it imposes on issuers as to how to make
public annual financial reports. It should be read in conjunction
with the Preliminary Announcement. Together these constitute the
material required by DTR 6.3.5 to be communicated to the media in
unedited full text through a Regulatory Information Service. This
material is not a substitute for reading the full Annual Report and
Financial Statements.
Principal Risks
The principal risks and
uncertainties faced by the Company are described below and note 1
provides detailed explanations of the risks associated with the
Company's financial instruments:
Risk description:
Economic, macro
and political - External events such
as global financial/political instability including terrorism, war,
climate change, disease including pandemics, protectionism,
inflation or deflation, economic shocks or recessions, the
availability of credit and movements in interest rates could affect
share prices and the valuation of investments.
Mitigation:
Each regular meeting of the Board provides a forum to discuss with
the Managers the general economic environment and to consider any
impact upon the investment portfolio and objectives. The investment
portfolio is diversified across end markets and regions.
No
change in overall risk in year
Risk description:
Liquidity and
capital structure - Failure by the
Company to meet its outstanding undrawn commitments could lead to
financial loss for shareholders. Failure to replace maturing
borrowings or enter agreement for new borrowings.
Mitigation:
The Board receives a detailed analysis of outstanding commitments
at each meeting. A medium term cashflow projection is also
provided. The Company had a borrowing facility which was not
due to expire until 19 June 2024. At 31 December 2023 the facility
was composed of a €25 million term loan and a £95 million revolving
credit facility.
No
change in overall risk in year
Risk description:
Regulatory
- Failure by the Company to meet or
adhere to regulatory/ legislative standards. Loss of investment
trust status. Regulatory or taxation changes resulting in
disincentives or market barriers limiting demand for the Company's
shares.
Mitigation: At each Board meeting
the Company's legal counsel provides an update on regulatory and
legislative developments. The Company employs Columbia
Threadneedle AM (Holdings) PLC as Company Secretary.
No
change in overall risk in year.
Risk description:
Personnel issues
- Loss of key personnel from the
Columbia Threadneedle Investments Private Equity team.
Mitigation: Regular meetings between the Board and senior staff of the
Manager. There is a six-month notice period to the investment
management agreement.
No
change in overall risk in year.
Risk description:
Fraud and cyber
risks - Theft of Company and
customer assets or data, including cyber risks.
Mitigation: The Depositary oversees
custody of investments and cash in accordance with the requirements
of the AIFMD. The Manager has extensive internal controls in
place. The Board receives a regular report on its effectiveness.
The Board also receives an annual internal controls report from the
Registrar, and the Depository.
No
change in overall risk in year.
Risk description:
Market- Poor investment
selection and/or performance against other assets classes and peer
group. Increased share price discount diminishes attractiveness of
Company to investors. A premium could represent a lost opportunity
to issue shares.
Mitigation:
At each meeting of the Board, the Directors monitor performance
against peer group and returns from the FTSE All Share Index.
Market intelligence is maintained via the Company's broker,
Singer Capital Markets and the provision of shareholder
analyses.
No
change in overall risk in year.
Risk description: ESG - Failure
to respond to increasing investor focus on ESG. Stranded assets
within the investment portfolio.
Mitigation:
The Manager has one of the longest established and largest
Responsible Investment teams in the City. The Columbia Threadneedle Investments Private Equity Team undertake an annual survey of the ESG
practices of underlying portfolio fund managers.
No
change in overall risk in year.
Risk description:
Operational - Failure of the
Manager's accounting systems or disruption to the Manager's or
service providers' business or business continuity failure could
lead to an inability to provide accurate reporting and monitoring
leading to a loss of Shareholder confidence.
Mitigation-
The Board receives annual internal controls
reports from the Manager, Registrar and the Depositary. The
administration system employed by the Manager is Efront. This is an
industry wide investment and accounting package used to record
transactions. Legal agreements/ engagement letters in place with
the Manager and service providers.
No change in overall risk in
year.
Emerging Risks
Emerging risks identified for the
Company include the post-acquisition integration of BMO GAM EMEA
with Columbia Threadneedle Investments, the retention of monies
invested in the Company held in maturing Child Trust Funds and
structural issues affecting the investor base for the wider
investment trust industry.
Rolling five-year viability assessment and
statement
The 2018 UK Corporate Governance
Code requires a Board to assess the future prospects for the
Company, and report on the assessment within the Annual
Report.
The Board considered that a number
of characteristics of the Company's business model and strategy
were relevant to this assessment:
• The
Board looks to long-term performance rather than short term
opportunities.
• The
Company's investment objective, strategy and policy, which are
subject to regular Board monitoring, mean that the Company is
invested in a well-diversified portfolio of funds and direct
investments and that the level of borrowings is
restricted.
• The
Company has a single class of Ordinary Shares.
• The
Company's business model and strategy is not time
limited.
Also relevant were a number of
aspects of the Company's operational arrangements:
• The
Company has title to all assets held.
•
Following the year end the Company entered into a revised loan
agreement with RBSI and State Street. The revised loan
agreement increased the €25 million term loan with RBSI to €60
million and retained the revolving credit facility with RBSI and
State Street at £95 million. The term of the agreement, which
was due to expire in June 2024 was extended to February
2027.
• The
Company aims to pay quarterly dividends with an annual yield
equivalent to not less than four per cent of the average of the
published net asset values per ordinary share for the previous four
financial quarters, or if higher in pence per share the highest
quarterly dividend previously paid. Dividends can be funded from
the revenue and realised capital reserves of the
Company.
•
Revenue and expenditure forecasts and projected cash requirements
are reviewed by the Directors at each Board Meeting.
Given the current volatility in
stock markets and the economic disruption arising from the war in
Ukraine, recent events in the Middle East and inflationary
concerns, the Directors also considered detailed cashflow
projections modelling various scenarios on the future drawdowns to
be paid and distributions to be received by the Company. These
projections were adjusted to consider various plausible scenarios
and took account of possible impacts upon the future NAV of the
Company and the ability of the Company to meet its loan covenants.
The Board concluded that there was a low probability that a
covenant breach related to capacity to meet cashflow requirements would occur. Furthermore the Board has
considered the remedies available if it appears that a covenant
breach is possible. Having considered the likelihood of the events
which could cause a covenant breach and the remedies available to
the Company, the Directors are of the view that the Company is well
placed to manage such an eventuality
satisfactorily.
In addition, the Board carried out a
robust assessment of the principal risks which could threaten the
Company's objective, strategy, future performance, liquidity and
solvency. These risks, mitigating actions in place to ensure the
Company's resilience and the processes for monitoring risks are set
out on page 30 and in Note 16 of the audited financial statements.
These principal risks were identified as relevant to the viability
assessment.
The Board took into account the
forecasted cash requirements of the Company, the long-term nature
of the investments held, the existence of the borrowing facility
and the effects of any significant future falls in investment
values on the ability to repay and re-negotiate borrowings,
maintain dividend payments and retain investors.
These matters were assessed over a
five-year period to April 2029, and the Board will continue to
assess viability over five-year rolling periods, taking account of
foreseeable severe but plausible scenarios. Note 16 to the
financial statements includes an analysis of the potential impact
of movements of interest rates and foreign exchange on net asset
value. A rolling five-year period represents the horizon over which
the Directors believe they can form a reasonable expectation of the
Company's prospects, balancing the Company's financial flexibility
and scope with the current uncertain outlook for longer-term
economic conditions affecting the Company and its
Shareholders.
Based on their assessment, and in
the context of the Company's business model, strategy and
operational arrangements set out above, the Board has a reasonable
expectation that the Company will be able to continue in operation
and meet its liabilities as they fall due over the five-year period
to April 2029. For this reason, the Board also considers it
appropriate to continue adopting the going concern basis in
preparing the Report and Audited Financial Statements.
Statement of Directors' Responsibilities
Directors'
Responsibilities
The Directors are responsible for
preparing the Annual Report and the financial statements in
accordance with UK adopted international accounting standards and
applicable law and regulations.
Company law requires the Directors
to prepare financial statements for each financial year. Under that
law the Directors are required to prepare the financial statements
and have elected to prepare the Company financial statements in
accordance with UK adopted international accounting standards.
Under Company law the Directors must not approve the financial
statements unless they are satisfied that they give a true and fair
view of the state of affairs of the Company and of the profit or
loss for the Company for that period.
In preparing these financial
statements, the Directors are required to:
•
select suitable accounting policies and then apply them
consistently;
• make
judgements and accounting estimates that are reasonable and
prudent;
•
state whether they have been prepared in accordance with UK adopted
international accounting standards, subject to any material
departures disclosed and explained in the financial
statements;
•
prepare the financial statements on the going concern basis unless
it is inappropriate to presume that the Company will continue in
business; and
•
prepare a Directors' report, a strategic report and Directors'
remuneration report which comply with the requirements of the
Companies Act 2006.
The Directors are responsible for
keeping adequate accounting records that are sufficient to show and
explain the Company's transactions and disclose with reasonable
accuracy at any time the financial position of the Company and
enable them to ensure that the financial statements comply with the
Companies Act 2006.
They are also responsible for
safeguarding the assets of the Company and hence for taking
reasonable steps for the prevention and detection of fraud and
other irregularities. The Directors are responsible for ensuring
that the Annual Report and Audited Financial Statements, taken as a
whole, are fair, balanced, and understandable and provides the
information necessary for shareholders to assess the Company's
performance, business model and strategy.
Website publication
The Directors are responsible for
ensuring the Annual Report and the financial statements are made
available on a website. Financial statements are published on the
Company's website in accordance with legislation in the United
Kingdom governing the preparation and dissemination of financial
statements, which may vary from legislation in other jurisdictions.
The maintenance and integrity of the Company's website is the
responsibility of the Directors. The Directors' responsibility also
extends to the ongoing integrity of the financial statements
contained therein.
Directors' responsibilities pursuant
to DTR4
• The
financial statements have been prepared in accordance with the
applicable set of accounting standards, give a true and fair view
of the assets, liabilities, financial position and profit and loss
of the Company.
• The
Annual Report includes a fair review of the development and
performance of the business and the financial position of the
Company, together with a description of the principal risks and
uncertainties that they face.
On behalf of the Board
Richard Gray
Chairman
Notes
1.
Financial instruments
The Company's financial instruments
comprise equity investments, cash balances, a bank loan and liquid
resources including debtors and creditors. As an investment trust,
the Company holds a portfolio of financial assets in pursuit of its
investment objective. From time to time the Company may make use of
borrowings to fund outstanding commitments and achieve improved
performance in rising markets. The downside risk of borrowings may
be reduced by raising the level of cash balances held.
The Company's investing activities
expose it to various types of risk that are associated with the
financial instruments and markets in which it invests. The most
important types of financial risk to which the Company is exposed
are market price risk, interest rate risk, liquidity and funding
risk, credit risk and foreign currency risk.
The nature and extent of the
financial instruments outstanding at the balance sheet date and the
risk management policies employed by the Company are discussed
below.
Market price risk
The Company's strategy for the
management of market price risk is driven by the Company's
investment policy. The management of market price risk is part of
the investment management process and is typical of private equity
investment. The portfolio is managed with an awareness of the
effects of adverse price movements through detailed and continuing
analysis, with an objective of maximising overall returns to
shareholders. Investments in unquoted stocks, by their nature,
involve a higher degree of risk than investments in the listed
market. Some of that risk can be, and is, mitigated by diversifying
the portfolio across geographies, business sectors and asset
classes, and by having a variety of underlying private equity
managers. New private equity managers are only chosen following a
rigorous due diligence process. The Company's overall market
positions are monitored by the Board on a quarterly
basis.
Interest rate risk
Some of the Company's financial
assets are interest bearing and, as a result, the Company is
subject to exposure to fair value interest rate risk due to
fluctuations in the prevailing levels of market interest
rates.
When the Company retains cash
balances the majority of the cash is held in deposit accounts. The
benchmark rate which determines the interest payments received on
cash balances is the bank base rate for the relevant
currency.
Liquidity and funding
risk
The Company's financial instruments
include investments in unlisted equity investments which are not
traded in an organised public market and which generally may be
illiquid. As a result, the Company may not be able to liquidate
quickly some of its investments in these instruments at an amount
close to their fair value in order to meet its liquidity
requirements, including the need to meet outstanding undrawn
commitments or to respond to specific events such as a
deterioration in the creditworthiness of any particular
issuer.
The Company's listed securities are
considered to be readily realisable.
The Company's liquidity risk is
managed on an ongoing basis by the Manager in accordance with
policies and procedures in place. The Company's overall liquidity
risks are currently monitored on a quarterly basis by the Board.
The Company maintains sufficient investments in cash and
readily realisable securities to pay accounts payable and accrued
expenses.
Credit risk
Credit risk is the risk that a
counterparty to a financial instrument will fail to discharge an
obligation or commitment that it has entered into with the Company.
The Manager has in place a monitoring procedure in respect of
counterparty risk which is reviewed on an ongoing basis. The
carrying amounts of financial assets best represents the maximum
credit risk exposure at the balance sheet date, hence no separate
disclosure is required.
Credit risk arising on transactions
with brokers relates to transactions awaiting settlement. Risk
relating to unsettled transactions is considered to be small due to
the short settlement period involved and the high credit quality of
the brokers used. The Manager monitors the quality of service
provided by the brokers used to further mitigate this
risk.
All the listed assets of the Company
(which are traded on a recognised exchange) are held by JPMorgan
Chase Bank, the Company's custodian.
The Company has an ongoing contract
with the Custodian for the provision of custody services. The
contract was reviewed and updated in 2014. Details of securities
held in custody on behalf of the Company are received and
reconciled monthly. The Depositary has regulatory responsibilities
relating to segregation and safe keeping of the Company's financial
assets, amongst other duties, as set out in the Report of the
Directors. The Board has direct access to the Depositary and
receives regular reports from it.
To the extent that the Manager
carries out management and administrative duties (or causes similar
duties to be carried out by third parties) on the Company's behalf,
the Company is exposed to counterparty risk. The Board assesses
this risk continuously through regular meetings with the management
of Columbia Threadneedle Investments (including the Fund Manager).
In reaching its conclusions, the Board also reviews Columbia
Threadneedle Investment's annual Audit and Assurance Faculty
Report.
The Company's cash balances are held
by a number of counterparties with a credit rating above BBB+.
Bankruptcy or insolvency of these counterparties may cause the
Company's rights with respect to the cash balances to be delayed or
limited. The Manager monitors the credit quality of the relevant
counterparties and should the credit quality or the financial
position of these counterparties deteriorate significantly the
Manager would move the cash holdings to another bank.
Foreign currency risk
The Company invests in overseas
securities and holds foreign currency cash balances which give rise
to currency risks. It is not the Company's policy to hedge this
risk on a continuing basis but it may do so from time to time. The
Company has a multi-currency revolving credit facility which allows
it to be drawndown in multiple currencies. There were no currency
forwards open at the year end.
2.
Copies of the Annual Report and Financial
Statements will be sent to shareholders and will be available at
the Company's registered office, Quartermile 4, 7a Nightingale Way,
Edinburgh, EH3 9EG and on its website www.ctprivateequitytrust.com
For more information, please
contact: